For decades, the luxury skincare industry operated as a high-margin consumer category—a commoditized market built on aesthetic masking. That era has concluded. We are currently witnessing a decisive migration of R&D capital into a new domain: Cellular Longevity. This is not a shift in marketing; it is a fundamental re-engineering of the industry's value chain, moving from cosmetic maintenance to high-barrier biological intervention. The market has bifurcated. On one side,

Imagine arriving at your office on a Monday morning, your schedule packed with high-stakes meetings, strategic decisions, and back-to-back travel. Yet, despite your accomplishments, something feels off: your energy dips, your focus wavers, and recovery from late nights seems slower than it used to be. For executives and high-performing leaders, these subtle declines are more than inconvenience—they are signals from your cells. Enter NAD+ (Nicotinamide Adenine Dinucleotide),